Detalhe da pesquisa
1.
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis.
Br J Haematol
; 191(5): 764-774, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583458
2.
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Lancet Oncol
; 10(1): 25-34, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095497
3.
Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex.
PLoS One
; 12(10): e0186235, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023494
4.
Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies.
Contraception
; 87(1): 107-12, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23040140
5.
Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer.
J Clin Oncol
; 24(24): 3919-26, 2006 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16921043